FreeStyle Libre 14 Day Flash Glucose Monitoring System

★★★★★ 4.4 127 reviews

US$46.90
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by www.optitherm.de
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$46.90
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Aug 18
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by www.optitherm.de
Free 30-day returns Details

Product details

Management number 242286070 Release Date 2026/07/19 List Price US$46.90 Model Number 242286070
Category

Intermittent scanning CGM for diabetes self-management. Measures glucose levels in interstitial fluid via a small sensor placed on the back of the upper arm. Glucose data is displayed when the sensor is scanned with the reader.


Key Features

  • 14-Day Wear – Sensor lasts up to two weeks without calibration.

  • Factory-Calibrated – No fingerstick calibration required.

  • Trend Data – Displays 8-hour glucose history and trend arrows.

  • Quick Scanning – Get results in seconds by scanning the sensor with the reader or compatible device.

  • Discreet & Comfortable – Slim, water-resistant sensor can be worn during everyday activities.


Technical Overview

Specification Details
Type Flash Glucose Monitoring System (Intermittent Scanning CGM)
Sensor Placement Posterior upper arm
Wear Duration Up to 14 days
Calibration Factory calibrated – no SMBG calibration needed
Alarms None (scan to view readings)
Trend Display 8-hour glucose history
Accuracy Mean Absolute Relative Difference: 11.4% (adults), 13.9% (children)
FDA Approval Year 2017
Water Resistance Yes, up to 1 meter for 30 minutes


Clinical Performance

  • Accuracy: Stable over 14 days; slightly reduced during hypoglycemia, post-glucose load, and exercise.

  • Glycemic Impact:

    • Systematic review (n=2,477) found CGMs improved time in range by ~70 min/day and reduced hypo- and hyperglycemia compared to SMBG.

    • Meta-analysis (n=2,173) found A1C reduction of −0.26% from baseline; not statistically significant compared with SMBG.


Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.4 out of 5
★★★★★
127 ratings | 52 reviews
How item rating is calculated
View all reviews
5 stars
81% (103)
4 stars
5% (6)
3 stars
2% (3)
2 stars
1% (1)
1 star
11% (14)
Sort by

There are currently no written reviews for this product.